Fast4wD Ogilvy, offices in both Washington DC and Oxford UK, is launched as a communications agency for patient recruitment and retention in clinical trials which will help to bring products quickly to market, a company release said.
Pharmaceutical companies are experiencing significant delays in the clinical development process, threatening future revenue streams and equity market expectations, while limiting access to important new treatment options for patients in need. The most significant bottleneck is due to difficulties with identifying, enrolling, and retaining suitable patients for the clinical trials required for product registration. Fast4wD Ogilvy's global services have been set up to address this need, the release continues.
"The US has a very different clinical trial recruitment and retention arena requiring additional insights and capabilities." says Chris Shreeve, head of the Fast4wD Ogilvy US office. "The Washington office already has highly skilled staff with expertise in clinical trial recruitment for pharmaceutical companies as well as government studies. Our strengths in social marketing, patient and disease advocacy combined with our Creative Studio and audio and television production capability means Fast4wD Ogilvy can provide clients with the global solution they are looking for," Chris claims.